WE INVITE YOU TO WATCH THE WEBINAR ON THE HEALTH ECONOMICS AND BIG DATA ANALYTICS PROGRAM WITH OUR PARTNER: LEGIA WARSAW! The webinar is available here.
Health Economics and Big Data Analytics - HEBDA is a unique full-time Master’s dual studies program with a practical profile, conducted entirely in English.
Health Economics is a new but dynamically developing science. It is the discipline of economics applied to the topic of health care. Health Economics provides a set of methods and analytical approaches to study the effectiveness, efficiency and value of health technologies with the ultimate objective of optimal allocation of healthcare resources. The business world is currently undergoing a revolution due to the increasing importance of Big Data, and the healtcare sector is no exception. "The Economist" states, that not oil but data is the most valuable resource of the 21st century. More information on health economics, and big data: here. In the upcoming years it is anticipated that there will be a large demand for data researchers and specialists in the healtcare industry.
Strategic partner of the program:
Declared partners of the program:
THE LEADER OF THE PROGRAM IS PROF. KATARZYNA KOLASA, PHD, who has more than 20 years of academic and occupational experience in the healthcare sector. In the past, she worked at both global and regional Health Economics & Outcomes Research (HEOR) functions at AstraZeneca and BiogenIdec being based in Sweden and Switzerland respectively. At Bristol Myers Squibb and Lundbeck she was leading Market Access teams in Central Eastern European (CEE) and Nordic Region. Her practical skills in the field of health economics were developed during six years em-ployment contract at the Kalmar County Council in Sweden as well.
For the last four years, Prof. Katarzyna Kolasa,PhD has been developing experience with the pricing & reimbursement challenges in the field of medical devices. Since 2016, Katarzyna has been represent-ing Straub Medical as Global Market Access Lead being the External Principal Consultant for that Swiss family owned company. Before that, Katarzyna was employed as a Senior HEOR Director at GE Healthcare.
She holds a PhD degree in health economics and is an author of almost 40 scientific IF publications in the field of health technology assessment and pharmacoeconomics. Katarzyna Kolasa reviews manuscripts submitted to such prestigious journals as Health Policy, Value in Health, Expert Review of Pharmacoeconomics & Outcomes Research, International Journal for Equity in Health and International Journal of Technology Assessment.
Her extensive knowledge in the field of health economics was acquired at University of York, University of Lund, and University of Bergen as well as during International Doc-toral Courses in Health Economics and Policy organized by the Swiss School of Public Health.
Prof. Kolasa heads the Health Economics & Healthcare Management Division (HeM) at the Kozminski University. She is the leader of the International Master Program Health Economics & Big Data at the Kozminski University financed by the research grant of the National Center for Research and Development which was listed as the best project in the POWER 2018 call. HeM Division vision is to become the leading research center in Poland in the field of digital health in Europe. It collaborates closely with health economics partners from the University of Lund, the University of Athens, University of Illinois, University of York and the University of Applied Science in Berlin.
Prof. Kolasa was nominated by the Ministry of Science to represent Poland in the COST Action CA17117, COST Association „Towards an International Network for Evidence-based Research in Clinical Health Research”. Since January 2019, she is co-chair of Global Special Interest Group for Digital Health establish at ISPOR.
This program is designed for you, if:
During the course of your studies you will acquire knowledge, skills and social competences, e.g. in the following:
After graduation, you will be able to start your career as specialists in institutions dealing with the organization and financing of health services, as well as enterprises responsible for the production or distribution of health technologies.
Job titles include:
Students have access to multiple study resources allowing them to collect all the necessary information for solving practical business problems as well as to dwell into academic science:
Classes take place from Monday to Friday in the morning and in the afternoon.
Admission for the Program is based on a written exam (online test). Candidates with the highest score will be qualified.
Application must include:
All documents issued in foreign languages should be translated into Polish or English by a sworn translator. The application must be complete in order to be qualified for the entry test.
Documents should be delivered to the Kozminski University Admission Office (room D/126) in person or by post. Admission period begins on 4th of February. The admission schedule:
|First batch||Second batch||Third batch|
|Submission of documents||04.02 - 20.05.2019||21.05 - 20.07.2019||21.07 - 20.09.2019|
|Date of online entry test||23.05.2019||23.07.2019||23.09.2019|
The admission fee for this program is 100 PLN.
Payment of the admission fee should be made to the following bank account:
Name of the bank: Pekao S.A. II o/Warszawa
Address: Grzybowska 53/57, Warszawa
Bank account number: 20 1240 1024 1111 0010 1646 0637
SWIFT code: PKOPPLPW
Foreigners who need a visa to study in Poland are additionally required to make payment of tuition for one full year of studies before we can issue documents necessary in the visa application process i.e. invitation to come to Poland and the admission decision. Admission commission issues a conditional acceptance letter including individual account number to which the payment should be transferred in Polish Złoty (PLN) calculated according to the exchange rates of the National Bank of Poland (www.nbp.pl). In case the candidate is denied a visa tuition is returned. Admission fee is non-refundable.